The market for gastrointestinal drugs is projected to expand significantly, starting from a valuation of approximately US$ 59,713.68 million in 2023 and expected to reach around US$ 106,304.81 million by 2031. This growth trajectory indicates a compound annual growth rate (CAGR) of 7.3% from 2023 to 2031. The primary drivers behind this market expansion include the rising incidence of gastrointestinal disorders and the ongoing advancements in biologics aimed at treating these conditions.
Gastrointestinal drugs are specifically formulated to address various disorders and ailments that impact the digestive system, which encompasses the esophagus, stomach, intestines, and associated organs. These medications play a crucial role in managing symptoms, alleviating discomfort, and treating the root causes of gastrointestinal diseases.
In 2023, North America emerged as a dominant region in the global gastrointestinal drugs market. This market is further divided into segments representing the US, Canada, and Mexico. Several factors contribute to the robust growth of the gastrointestinal drugs market in North America, including the increasing rates of gastrointestinal diseases linked to lifestyle changes, government initiatives aimed at prevention and treatment, a well-established healthcare infrastructure, a thriving pharmaceutical sector, comprehensive reimbursement policies, and the presence of major industry players.
Among these, the United States stands out as the largest market for gastrointestinal drugs. The rising prevalence of gastrointestinal disorders in the US directly fuels the demand for these medications. Conditions such as Crohn's disease and ulcerative colitis are among the most prevalent inflammatory bowel diseases (IBD). According to the Crohn's & Colitis Foundation of America (CCFA), approximately 70,000 new IBD cases are diagnosed annually in the US. The prevalence of IBD has seen a notable increase from 2011 to 2020, with estimates suggesting that nearly 1 in 100 Americans are affected, totaling around 2.4 million individuals. Furthermore, increased funding for research and development in the field of gastrointestinal diseases is anticipated to enhance the focus on creating innovative treatment options. A report titled "Endometriosis Is Undervalued," published in 2022, highlighted that Crohn's disease research received US$ 90 million in funding, equating to approximately US$ 130.07 per patient.
The growth of the market is also supported by approvals from the US Food and Drug Administration (FDA). For example, in May 2020, the FDA approved Qinlock (ripretinib) tablets as a fourth-line treatment for advanced gastrointestinal stromal tumors (GIST). More recently, in May 2024, Strides Pharma received FDA approval for a generic version of Sucralfate Oral Suspension, 1gm/10 mL, which is indicated for treating gastrointestinal diseases, stomach ulcers, gastroesophageal reflux disease (GERD), and stomach inflammation, as well as for preventing stress ulcers.
Thus, the growth of the gastrointestinal drugs market is primarily driven by the increasing prevalence of gastrointestinal disorders, ongoing developments by market participants, and the presence of significant industry players in the US.
Strategic Initiatives in Gastrointestinal Drugs to Provide Market Opportunities in Future
Companies within the gastrointestinal drugs sector are actively pursuing strategic initiatives such as product approvals, collaborations, funding, partnerships, and the launch of new products. These efforts are aimed at enhancing sales, expanding geographic reach, and improving their capabilities to serve a broader customer base. Below are some notable strategic initiatives undertaken by key players in the gastrointestinal drugs market:
- In September 2023, Vivante Health secured US$ 31 million in a Series B funding round led by Mercato Partners, a new investor, to enhance its digital digestive health platform. This funding is primarily attributed to the recent improvements in the GIThrive platform, which showcases its unique capability to deliver timely and appropriate care. The Series B capital will facilitate ongoing technological advancements aimed at predicting the onset and progression of gastrointestinal conditions while providing comprehensive virtual care.
- In May 2024, Strides Pharma Global Pte. Ltd received FDA approval to market the generic version of Sucralfate Oral Suspension, 1gm/10 mL. This medication is utilized for treating gastrointestinal disorders such as stomach ulcers, GERD, and stomach inflammation, in addition to preventing stress ulcers.
- In May 2023, AbbVie obtained FDA approval for RINVOQ (upadacitinib) to treat adults with mild to severe active Crohn's disease who have not responded adequately or are intolerant to one or more TNF blockers. This marks the seventh FDA approval for RINVOQ across various fields, including rheumatology, dermatology, and gastroenterology, where it is now indicated for both ulcerative colitis and Crohn's disease.
Consequently, the strategic initiatives undertaken by various companies focused on developing treatments for digestive diseases are expected to create significant growth opportunities for the gastrointestinal drugs market in the years ahead.
Gastrointestinal Drugs Market: Competitive Landscape and Key Developments
Key players in the gastrointestinal drugs market include Sanofi SA, GSK Plc, Johnson & Johnson, Bausch Health Companies Inc, AstraZeneca Plc, Takeda Pharmaceutical Co Ltd, AbbVie Inc, Bayer AG, Celltrion Inc, and Pfizer Inc.
The report on the gastrointestinal drugs market references primary and secondary sources, including the US Food and Drug Administration, the International Foundation for Gastrointestinal Disorders, the American College of Gastroenterology, and The International Union of Basic and Clinical Pharmacology (IUPHAR).
TABLE OF CONTENTS
1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Gastrointestinal Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Gastrointestinal Drugs Market - Key Market Dynamics
5.1 Gastrointestinal Drugs Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Cases of Gastrointestinal Diseases
5.2.2 Increasing Development of Biologics
5.3 Market Restraints
5.3.1 High Cost of Biologics
5.3.2 Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques
5.6 Impact of Drivers and Restraints:
6. Gastrointestinal Drugs Market - Global Market Analysis
6.1 Gastrointestinal Drugs Market Revenue (US$ Million), 2021-2031
6.2 Gastrointestinal Drugs Market Forecast Analysis
7. Gastrointestinal Drugs Market Analysis - by Drug Class
7.1 Biologics
7.1.1 Overview
7.1.2 Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Antidiarrheal and Laxatives
7.2.1 Overview
7.2.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Anti-inflammatory Drugs
7.4.1 Overview
7.4.2 Anti-inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Antiemetic and Antinauseants
7.5.1 Overview
7.5.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8. Gastrointestinal Drugs Market Analysis - by Application
8.1 Irritable Bowel Syndrome
8.1.1 Overview
8.1.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Inflammatory Ulcerative Colitis
8.2.1 Overview
8.2.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Crohns Disease
8.3.1 Overview
8.3.2 Crohns Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Gastroenteritis
8.4.1 Overview
8.4.2 Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Celiac Disease
8.5.1 Overview
8.5.2 Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9. Gastrointestinal Drugs Market Analysis - by Route Of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Parenteral
9.2.1 Overview
9.2.2 Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10. Gastrointestinal Drugs Market Analysis - by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11. Gastrointestinal Drugs Market - Geographical Analysis
11.1 North America
11.1.1 North America Gastrointestinal Drugs Market Overview
11.1.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
11.1.2.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
11.1.2.3 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
11.1.2.4 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.1.3 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
11.1.3.1 United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.1.1 United States: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.1.2 United States: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.1.3 United States: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.1.4 United States: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.1.3.2 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.2.1 Canada: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.2.2 Canada: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.2.3 Canada: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.2.4 Canada: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.1.3.3 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.1.3.3.1 Mexico: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.1.3.3.2 Mexico: Gastrointestinal Drugs Market Breakdown, by Application
11.1.3.3.3 Mexico: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.1.3.3.4 Mexico: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2 Europe
11.2.1 Europe Gastrointestinal Drugs Market Overview
11.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
11.2.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
11.2.2.3 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
11.2.2.4 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.3 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
11.2.3.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.1.1 Germany: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.1.2 Germany: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.1.3 Germany: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.1.4 Germany: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.2 United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.2.2 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.2.3 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.2.4 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.3 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 France: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.3.2 France: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.3.3 France: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.3.4 France: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.4 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.4.1 Italy: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.4.2 Italy: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.4.3 Italy: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.4.4 Italy: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.5 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.5.1 Spain: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.5.2 Spain: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.5.3 Spain: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.5.4 Spain: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2.3.6 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3.6.1 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.3.6.2 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Application
11.2.3.6.3 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.3.6.4 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3 Asia Pacific
11.3.1 Asia Pacific Gastrointestinal Drugs Market Overview
11.3.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
11.3.2.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
11.3.2.3 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
11.3.2.4 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.3.3 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
11.3.3.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 China: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.1.2 China: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.1.3 China: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.1.4 China: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.2 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Japan: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.2.2 Japan: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.2.3 Japan: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.2.4 Japan: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.3 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 India: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.3.2 India: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.3.3 India: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.3.4 India: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.4 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Australia: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.4.2 Australia: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.4.3 Australia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.4.4 Australia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.5 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 South Korea: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.5.2 South Korea: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.5.3 South Korea: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.5.4 South Korea: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3.3.6 Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.3.3.6.2 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Application
11.3.3.6.3 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.3.3.6.4 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4 Middle East & Africa
11.4.1 Middle East & Africa Gastrointestinal Drugs Market Overview
11.4.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
11.4.2.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
11.4.2.3 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
11.4.2.4 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.4.3 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.1.2 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.1.3 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.1.4 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.2 South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 South Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.2.2 South Africa: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.2.3 South Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.2.4 South Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.3 United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.3.2 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.3.3 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.3.4 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4.3.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.4.3.4.2 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Application
11.4.3.4.3 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.4.3.4.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5 South & Central America
11.5.1 South & Central America Gastrointestinal Drugs Market Overview
11.5.2 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
11.5.2.2 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
11.5.2.3 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
11.5.2.4 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.5.3 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
11.5.3.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.1.1 Brazil: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.1.2 Brazil: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.1.3 Brazil: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.1.4 Brazil: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5.3.2 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 Argentina: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.2.2 Argentina: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.2.3 Argentina: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.2.4 Argentina: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5.3.3 Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Drug Class
11.5.3.3.2 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Application
11.5.3.3.3 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.5.3.3.4 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Gastrointestinal Drugs Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Sanofi SA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GSK Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson & Johnson
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AstraZeneca Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AbbVie Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bayer AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Celltrion Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pfizer Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Gastrointestinal Drugs Market Segmentation
Table 2. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 3. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 4. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 5. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 6. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 7. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 8. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 9. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 10. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 11. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 12. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 13. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 14. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 15. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 16. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 17. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 18. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 19. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 21. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 22. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 23. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 24. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 25. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 26. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 27. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 29. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 30. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 31. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 32. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 33. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 34. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 35. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 36. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 37. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 38. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 39. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 40. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 41. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 42. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 43. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 44. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 45. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 46. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 47. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 48. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 49. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 50. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 51. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 52. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 53. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 54. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 55. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 57. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 58. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 59. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 60. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 61. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 62. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 63. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 64. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 65. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 66. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 67. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 68. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 69. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 70. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 71. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 72. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 73. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 74. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 75. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 76. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 77. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 78. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 79. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 80. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 81. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 82. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 83. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 84. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 85. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 86. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 87. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 88. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 89. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 90. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 91. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 92. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 93. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 94. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 95. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 96. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 97. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 98. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 99. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 100. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 101. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 102. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 103. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 104. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 105. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 106. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 107. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 108. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 109. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 110. Recent Organic Growth Strategies in Gastrointestinal Drugs Market
Table 111. Recent Inorganic Growth Strategies in the Gastrointestinal Drugs Market
Table 112. Glossary of Terms, Gastrointestinal Drugs Market
LIST OF FIGURES
Figure 1. Gastrointestinal Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Gastrointestinal Drugs Market Revenue (US$ Million), 2021-2031
Figure 5. Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 6. Gastrointestinal Drugs Market Share (%) - by Drug Class (2023 and 2031)
Figure 7. Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Antidiarrheal and Laxatives: Gastrointestinal Drugs Market
The List of Companies - Gastrointestinal Drugs Market
- Sanofi SA
- GSK Plc
- Johnson & Johnson
- Bausch Health Companies Inc
- AstraZeneca Plc
- Takeda Pharmaceutical Co Ltd
- AbbVie Inc
- Bayer AG
- Celltrion Inc
- Pfizer Inc